← SynDRA
APY29
SynDRA canonical compound SYN1969803 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ERN1 |
| Mechanism of action | serine/threonine kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- serine/threonine kinase inhibitor
- ERN1 INHIBITOR
Cross-references
Synonyms
- APY-29
- N~2~-1h-Benzimidazol-5-Yl-N~4~-(3-Cyclopropyl-1h-Pyrazol-5-Yl)pyrimidine-2,4-Diamine
- N2-1H-Benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine
- N2-(1H-benzo[d]imidazol-6-yl)-N4-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
- (E)-N-(6-((5-cyclopropyl-1H-pyrazol-3-yl)imino)-1,6-dihydropyrimidin-2-yl)-1H-benzo[d]imidazol-6-amine
- APY 29;APY-29
- CHEMBL1231018
- SCHEMBL12045464
- SCHEMBL20438003
- SCHEMBL21067744
- EX-A305
- BCP09071
- MFCD28023582
- s6623
- ZINC40163635
- AKOS024458384
- DB07382
- 2-N-(3H-benzimidazol-5-yl)-4-N-(5-cyclopropyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine
- NCGC00379217-02
- NCGC00379217-03
- AK547105
- BS-14553
- DA-47145
- HY-17537
- QC-11386
- AB0098417
- FT-0700119
- J3.589.967G
- Q27096602
- 2,4-Pyrimidinediamine, N2-1H-benzimidazol-6-yl-N4-(5-cyclopropyl-1H-pyrazol-3-yl)-
Look up APY29 in the interactive SynDRA portal →